Cannabis Law Report

JULY 23, 2019

(TSXV: LG and OTC-QB: LGGCF) (“ LGC ”) is pleased to announce that it has paid the 2 nd Tranche, as contractually agreed, in acquiring an equity interest in the Italian pharmaceutical company, Freia Farmaceutici Srl (“Freia”). This EU pharmaceutical entity is an optimal addition to LGC. Tel: (416) 644-2020 or (514) 939-3989.

Pharmaceutical 45

Pharmaceutical Seed-To-Sale Compliance Compliance 45

Veriheal

JANUARY 21, 2021

Although many of these athletes did not consume cannabis prior to games, fights, and other competitions but rather in their own free times, it did not matter as cannabis has been listed in many of the leagues’ anti-doping and drug policies since their inception. A Statement Regarding the Changes. Athletes That Have Come Forward.

Policy 57

Policy THC Therapy Chronic Pain 57

SpeedWeed

APRIL 9, 2021

Last year, researchers from Rice University’s Baker Institute for Public Policy undertook a new study in order to “gain insight into the needs and experiences” of the state’s medical pot users. The post 61% of Medical Cannabis Users in Texas Said Weed Helped Them Get off Pharmaceuticals appeared first on SpeedWeed.

Pharmaceutical 52

Pharmaceutical Chronic Pain Programs Patients 52

Cannabis Law Report

SEPTEMBER 10, 2021

Brazilian pharmaceutical company Prati-Donaduzzi, whose 20 year patent to produce CBD oil was recently revoked, offers an alternative to imported products—even though it is manufactured with imported raw material.

Policy 103

Policy Oil Concentrates Pharmaceutical 103

Cannabis Law Report

JULY 1, 2021

The Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics at Harvard Law School is engaged in a three-year initiative to examine the ethical, legal, and social implications of psychedelics research, commerce, and therapeutics. Here’s the press release. The Project on Psychedelics Law and Regulation (POPLAR).

Law 59

Law Policy Research and Development Clinical Trials 59

Cannabis Law Report

JUNE 28, 2021

PUTRAJAYA: The courts cannot sidestep any government policy on cannabis unless it is against the law, a Federal Court bench said. Zawawi said the primary authority with jurisdiction over cannabinoid drugs is the National Pharmaceutical Regulatory Agency established under the health ministry. “We

Policy 75

Policy Law Oil Cannabinoids 75

The Blunt Truth

JANUARY 20, 2023

Speaking of CBD, Google makes changes to its advertising policies. CBD ADVERTISING If you’ve wondered why you’ve never seen CBD advertising when you’re searching Google (even if you blog about cannabis news every week…), the answer is that the products are currently on Google’s Unapproved Pharmaceuticals and Supplements list.

Pharmaceutical 84

Pharmaceutical CBD Hemp Collective 84

Cannabis Law Report

SEPTEMBER 10, 2021

1 producer of pharmaceutical-grade cannabis nutrients since 1999, creating an intuitive line of products trusted by growers all over the world. Advice and interface with all departments to implement procedures and policies. Ensure compliance with laws, regulations, and policies. Flexible PTO policy. JUNIOR COUNSEL.

Compliance 98

Compliance Compliance Safety Policy 98

Cannabis Law Report

NOVEMBER 23, 2021

SOMAÍ Pharmaceuticals Unipessoal LDA, or SOMAÍ, recently received an “innovative products” grant of 2.7 Provided by the Portugal 2020 committee, the grant will help Somaí continue its mission of developing high-quality and efficacious cannabis pharmaceuticals for the European market. million euros ($3.07 Source: [link].

Pharmaceutical 52

Pharmaceutical Research and Development Cannabinoids Extraction 52

Cannabis Law Report

JULY 27, 2022

The next lane is pharmaceutical. This lane makes cannabis available to companies to develop pharmaceutical-grade medicines. These policy and commercial distinctions have taken hold around the globe. These countries have developed various means of commercial cannabis policy reform. This is the true medical marijuana lane.

Supply Chain 52

Supply Chain Pharmaceutical Policy Food 52

Cannabis Law Report

APRIL 11, 2022

Rowan University in New Jersey now offers an MBA in Cannabis Commercialization with courses ranging from Cannabis Legislation, Regulations, and Policy to Advanced Chemical Analysis of Cannabinoids. Read more at [link].

Research and Development 52

Research and Development Policy Decriminalization Pharmaceutical 52

Project CBD

JULY 28, 2023

You need access to sophisticated analytical methods to discern product purity from the isomeric byproducts formed, which is why production from hemp-derived cannabinoid products needs to be done under the appropriate FDA regulations for API [active pharmaceutical ingredient] synthesis and manufacturing.

THC 212

THC Cannabinoids Hemp Research and Development 212

Cannabis Law Report

NOVEMBER 23, 2019

for the production R&D of pharmaceutical grade standardised cannabis. Here the company shares their evolution with Health Europa, exploring the production of pharmaceutical grade standardised cannabis. KANNABEIRA® is a project and a registered trademark under the company Green Donation, Ltd. KANNABEIRA and standardised cannabis.

Pharmaceutical 45

Pharmaceutical Research and Development Cultivation Environment 45

Cannabis Law Report

JUNE 1, 2021

There isn’t much writing at all on Brazilian policy issues regarding cannabis so this is well worth spending some time with. Here’s their introduction. The year 2021 began with heavy regret in the marijuana scene in Brazil, with the news of the death of Priest Antônio Luiz Madchioni, affectionately known as “Padre Ticão.”

Medicine 95

Medicine Decriminalization Pharmaceutical Marijuana 95

NORML

NOVEMBER 8, 2019

Prohibiting VA doctors from recommending cannabis to qualifying patients, while continuing to rely on pharmaceuticals drugs like opioids as a treatment, is both a dangerous and illogical policy.

Access 204

Access Marijuana Treatment Legislation 204

Cannabis Law Report

AUGUST 27, 2021

The policy for deregulation was announced on the 23rd when representatives of growers in Tochigi, Mie, Gifu Prefecture and Hokkaido visited Mr. Mitsuaki Kamada, Director of the Pharmaceutical and Living Hygiene Bureau of the Ministry of Health, Labor and Welfare. There are also regulations that are clearly overkill.

Pharmaceutical 98

Pharmaceutical Cultivation Data Policy 98

NORML

JULY 1, 2019

Previously, Virginia’s five licensed medical cannabis providers, called pharmaceutical processors, would have been limited to dispensing only oils when they open their doors later this year. Virginia NORML has worked diligently alongside these legislators in their continued efforts to advance patient-focused medical cannabis policies.

Law 254

Law Patients Access Oil 254

Cannabis Law Report

JUNE 5, 2021

The Harare government has also approved the establishment of the Green Industry Fund, to promote local beneficiation, skills transfer and development of the local pharmaceutical industry. 100% foreign ownership a ‘significant departure from previous policy’.

Medicine 105

Medicine Pharmaceutical Agriculture Policy 105

The Cannigma

JUNE 14, 2021

We are allowed to cultivate, manufacture, research, analyze and distribute cannabis for scientifical, medical and pharmaceutical research. This is in my opinion, the most meaningful cannabis policy reform in the United States in the last five decades.”. “We think it’s really groundbreaking,” Hodgin said. “We Shutterstock).

DEA 133

DEA Research and Development Clinical Trials Pharmaceutical 133

Veriheal

DECEMBER 15, 2023

There is hope for the future, but rescheduling MDMA and subjecting it to rigorous testing and policy considerations are still necessary steps. If the measure passes, MDMA will make history as the first psychedelic approved for pharmaceutical use.

Therapy 105

Therapy Decriminalization Treatment Pharmaceutical 105

The Cannigma

FEBRUARY 8, 2021

But when it comes to law and policy, what are the definitive terms we should be using when talking about cannabis? Published in Drug Science, Policy and Law , the study is the first of its kind to examine the different nomenclature systems used for cannabis in the worlds of law and academia. Not always, according to a new study.

Cannabinoids 132

Cannabinoids Sativa Policy Hemp 132

Cannabis Law Report

MARCH 5, 2020

The WHO recommended last year that the UN Commission remove cannabis from its list of banned substances and reschedule the plant as a pharmaceutical drug. Some countries in Europe already regulate medical cannabis as a pharmaceutical drug, and the WHO recommendations would only align international policy with those specific national rules.

Pharmaceutical 45

Pharmaceutical Policy Medicine Business 45

Cannabis Law Report

NOVEMBER 13, 2021

The FDA has been reviewing over-the-counter CBD since 2019 but has yet to signal any change from its existing policy – that the cannabinoid is an active ingredient in a pharmaceutical drug and shouldn’t be taken without a doctor’s oversight. Califf has said nothing publicly about cannabinoids such as CBD. More at [link].

Cannabinoids 52

Cannabinoids Therapy Pharmaceutical Hemp 52

United Patients Group

JANUARY 4, 2024

These roles complement healthcare practitioners’ vital work and shape the future of healthcare delivery, policy, and administration. Tasked with overseeing budgets, managing personnel, and implementing policies, healthcare administrators are instrumental in maintaining the integrity of healthcare delivery systems.

Research and Development 52

Research and Development Patients Data Policy 52

Cannabis Law Report

JULY 21, 2022

Kabir Nath brings decades of experience in the health care industry to his new role, most recently serving as Senior Managing Director of global pharmaceuticals at Otsuka Pharmaceutical Co.,

Therapy 52

Therapy Research and Development Pharmaceutical Patients 52

Cannabis Law Report

FEBRUARY 5, 2020

The success of our pharmaceutical arm Eco Equity over the past 18 months shows there is appetite for investment in the industry. The launch, which took place at London’s Gherkin, featured a panel discussion on ‘the future of the UK medicinal cannabis policy’. Source: [link].

Seed-To-Sale 59

Seed-To-Sale Pharmaceutical Medicine Cultivation 59

Veriheal

JUNE 19, 2023

The prominent players, as explained by the psychedelic market report, include Pfizer, Verrian, GlaxoSmithKline, COMPASS Pathways PLC, MindMed, Janssen Pharmaceuticals PLC, HAVN Life Sciences, Seelos Therapeutics, Field Trip Health, amongst others.

Therapy 109

Therapy Treatment Patients Policy 109

Cannabis Law Report

JANUARY 16, 2020

The European Medicinal Cannabis Association (EUMCA), the newly formed Brussels-based industry body which advocates for European evidence-based policy to improve patient access to high-quality cannabis treatment, has announced the appointment of Professor Jones, CBE, FMedSci, as its new Chairman. Professor Jones.

Medicine 59

Medicine Research and Development Pharmaceutical Policy 59

Cannabis Law Report

MARCH 9, 2022

He has experience building strong technology driven companies and positioning them in sectors driven by waves of public policy change. MGC Pharmaceuticals (ASX:MXC) . MGC Pharmaceutical is a European based bio-pharma company specialising in the production and development of phytocannabinoid-derived medicines.

Medicine 52

Medicine Pharmaceutical Strains Cannabis 52

Veriheal

FEBRUARY 21, 2023

Although respondents frequently have to choose “other conditions” to meet MMJ requirements, it’s an unfortunate reality for millions due to restrictive laws and policies, further skewing data towards more universally accepted health issues.

Access 98

Access Patients Chronic Pain Conditions 98

Veriheal

JUNE 20, 2022

.” The LPP’s mission is: “Through intervention, advocacy, and awareness campaigns the Last Prisoner Project works to redress the past and continuing harms of these unjust laws and policies.” The FDA has also approved a few cannabis-based pharmaceutical drugs. According to the U.S.

Chronic Pain 96

Chronic Pain Advocacy Pharmaceutical Legalization 96

Cannabis Law Report

SEPTEMBER 26, 2021

They provide interpretation and risk-impact analysis on updated regulatory guidelines/policies/regulations and delivers training/communication, as needed. pharmaceutical, biotechnology, science, chemistry, microbiology or biology). Degree in a relevant field (i.e. Graduate Certificate in Regulatory Affairs/Quality considered an asset.

Environment 52

Environment Compliance Compliance Pharmaceutical 52

Cannabis Law Report

APRIL 21, 2022

We are a new kind of pharmaceutical company that prioritizes public benefit over profit and is committed to sustainability, accountability, and transparency. The State Government Affairs Lead will oversee MAPS PBC’s policy efforts at the state level. Experience in healthcare, mental health, or pharmaceutical/biotech industry required.

Advocacy 52

Advocacy Therapy Clinical Trials Environment 52

Cannabis Law Report

MARCH 29, 2022

to acquire Dutch medical cannabis company APIRx Pharmaceutical BV. On the other hand, the international marketplace is far more focused on true medicinal, pharmaceutical development, infrastructure, data, formulations, and the continued development thereof. The next day, on March 24 th , Australia’s Incannex Healthcare paid $93.3M

Pharmaceutical 52

Pharmaceutical Cannabinoids Data Policy 52

MMJ Recs

MARCH 23, 2024

Legalization presents an opportunity to address historical injustices associated with cannabis prohibition, particularly concerning marginalized communities disproportionately affected by past enforcement policies. Legalization may expand treatment choices for certain conditions, potentially reducing reliance on traditional pharmaceuticals.

Legalization 52

Legalization Access Programs Education 52

The Blunt Truth

APRIL 20, 2021

Although not immediately effective, New Mexico and Virginia employers should immediately assess the implications of the laws on their current policies and drug testing practices. Virginia went further by enacting the first law providing employment protections to individuals using cannabis oil. Virginia’s Cannabis Oil Law.

Recreational 77

Recreational Legalization Oil Extraction 77

Cannabis Law Report

JULY 4, 2021

In late 2019, BNYM announced its cannabis securities policy which prohibited clients (including a large number of Australian brokers), dealing in listed cannabis related businesses (CRB) mainly due to cannabis remaining illegal at the US federal level.

Banking 105

Banking Pharmaceutical Cannabis Policy 105